2% Ganciclovir Controlled Posner-Schlossman Syndrome Relapse and Reduced the Chance of Corticosteroid Dependence: A Large Cohort in East China

References

• Shazly TA, Aljajeh M, Latina MA. Posner-Schlossman glaucomatocyclitic crisis. Semin Ophthalmol. 2011;26(4–5):282–284. doi:10.3109/08820538.2011.605821.
   PubMed Web of Science ®Google Scholar
• Posner A, Schlossman A. Syndrome of unilateral recurrent attacks of glaucoma with cyclitic symptoms. Arch Ophthal. 1948;39(4):517–535. doi:10.1001/archopht.1948.00900020525007.
   PubMedGoogle Scholar
• Megaw R, Agarwal PK. Posner-Schlossman syndrome. Surv Ophthalmol. 2017;62(3):277–285. doi:10.1016/j.survophthal.2016.12.005.
   PubMed Web of Science ®Google Scholar
• Chee SP, Bacsal K, Jap A, Se-Thoe SY, Cheng CL, Tan BH. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol. 2008;145(5):834–840. doi:10.1016/j.ajo.2007.12.015.
   PubMed Web of Science ®Google Scholar
• Chee SP, Jap A. Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol. 2008;146(6):883–9 e1. doi:10.1016/j.ajo.2008.09.001.
   PubMed Web of Science ®Google Scholar
• Hedayatfar A, Chee SP. Posner-Schlossman syndrome associated with cytomegalovirus infection: a case series from a non-endemic area. Int Ophthalmol. 2014;34(5):1123–1129. doi:10.1007/s10792-014-9928-6.
   PubMed Web of Science ®Google Scholar
• Kandori M, Miyazaki D, Yakura K, et al. Relationship between the number of cytomegalovirus in anterior chamber and severity of anterior segment inflammation. Jpn J Ophthalmol. 2013;57(6):497–502. doi:10.1007/s10384-013-0268-2.
   PubMed Web of Science ®Google Scholar
• Kongyai N, Sirirungsi W, Pathanapitoon K, et al. Viral causes of unexplained anterior uveitis in Thailand. Eye (Lond). 2012;26(4):529–534. doi:10.1038/eye.2011.363.
   PubMed Web of Science ®Google Scholar
• Li J, Ang M, Cheung CMG, Boyaka PN, et al. Aqueous cytokine changes associated with Posner-Schlossman syndrome with and without human cytomegalovirus. PLoS One. 2012;7(9):e44453. doi:10.1371/journal.pone.0044453.
   PubMed Web of Science ®Google Scholar
• Hwang YS, Shen CR, Chang SH, et al. The validity of clinical feature profiles for cytomegaloviral anterior segment infection. Graefes Arch Clin Exp Ophthalmol. 2011;249(1):103–110. doi:10.1007/s00417-010-1510-y.
   PubMed Web of Science ®Google Scholar
• Koizumi N, Suzuki T, Uno T, et al. Cytomegalovirus as an etiologic factor in corneal endotheliitis. Ophthalmology. 2008;115(2):292–297.e3. doi:10.1016/j.ophtha.2007.04.053.
   PubMed Web of Science ®Google Scholar
• Kam KW, Wong CH, Ho M, Sze RKH, Chan PKS, Young AL. Iris depigmentation in the prediction of cytomegalovirus anterior uveitis. Ocul Immunol Inflamm. 2022;30(7–8):1775–1780.
   PubMed Web of Science ®Google Scholar
• Ohashi Y, Kinoshita S, Mano T, Kiritoshi A, Ohji M. Idiopathic corneal endotheliopathy. A report of two cases. Arch Ophthalmol. 1985;103(11):1666–1668. doi:10.1001/archopht.1985.01050110060025.
   PubMedGoogle Scholar
• Touhami S, Qu L, Angi M, et al. Cytomegalovirus anterior uveitis: clinical characteristics and long-term outcomes in a French series. Am J Ophthalmol. 2018;194:134–142. doi:10.1016/j.ajo.2018.07.021.
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Matsumaru Y, Nose S, Sasaki H, Kitahara T. Evaluation of the safety of 2.0% ganciclovir eye drops for hospital preparation. Yakugaku Zasshi. 2018;138:107–110.
   PubMed Web of Science ®Google Scholar
• Zhai RY, Xu H, Kong XM, Wang ZJ. Effect of 2% ganciclovir eye drops on cytomegalovirus positive Posner-Schlossman syndrome. Zhonghua Yan Ke Za Zhi. 2018;54(11):833–838. doi:10.3760/cma.j.issn.0412-4081.2018.11.007.
   PubMedGoogle Scholar
• Keorochana N, Choontanom R. Efficacy and safety of an extemporaneous preparation of 2% ganciclovir eye drops in CMV anterior uveitis. BMJ Open Ophthalmol. 2017;2(1):e000061. doi:10.1136/bmjophth-2016-000061.
   PubMed Web of Science ®Google Scholar
• Kuo YW, Chang EC, Lee CY, et al. Effectiveness of topical ganciclovir 2% monotherapy versus combined steroid therapy in cytomegalovirus endotheliitis. J Clin Med. 2022;11(19):5811. doi:10.3390/jcm11195811.
   PubMed Web of Science ®Google Scholar
• Sheng Q, Zhai R, Fan X, Kong X, Takeuchi M. The analysis of dynamic changes and prognosis of Posner–Schlossman syndrome with cytomegalovirus infection and antiviral therapy. J Ophthalmol. 2021;2021:1–6. doi:10.1155/2021/6687929.
   Web of Science ®Google Scholar
• Sheng Q, Zhai R, Fan X, Kong X. 2% ganciclovir eye drops control Posner-Schlossman syndrome relapses with/without cytomegalovirus intraocular reactivation. Front Med (Lausanne). 2022;9:848820. doi:10.3389/fmed.2022.848820.
   PubMed Web of Science ®Google Scholar
• Zhai R, Wang Z, Sheng Q, Fan X, Kong X, Sun X. Polymorphisms of the cytomegalovirus glycoprotein B genotype in patients with Posner-Schlossman syndrome. Br J Ophthalmol. 2022;106(9):1240–1244. doi:10.1136/bjophthalmol-2020-318284.
   PubMed Web of Science ®Google Scholar
• Wang XL, Wang ZJ, Tang L, Cao WW, Sun XH. Determination of cytomegalovirus IgG synthesis by the albumin correction in the aqueous humor of posner-schlossmann syndrome. Zhonghua Yan Ke Za Zhi. 2017;53(2):104–108. doi:10.3760/cma.j.issn.0412-4081.2017.02.007.
   PubMedGoogle Scholar
• Lenglinger M, Schick T, Pohlmann D, Pleyer U. Cytomegalovirus-positive Posner-Schlossman syndrome: impact on corneal endothelial cell loss and retinal nerve fiber layer thinning. Am J Ophthalmol. 2022;237:290–298. doi:10.1016/j.ajo.2021.12.015.
   PubMed Web of Science ®Google Scholar
• Wang L, Wang Z, Ma J, et al. Comparison of intraocular antibody measurement, quantitative pathogen PCR, and metagenomic deep sequencing of aqueous humor in secondary glaucoma associated with anterior segment uveitis. Ocul Immunol Inflamm. 2022;30(1):153–159. doi:10.1080/09273948.2020.1776883.
   PubMed Web of Science ®Google Scholar
• Leleu I, Jhanji V, Touhami S, et al. Clinical features and diagnosis of anterior segment inflammation related to cytomegalovirus in immunocompetent African, Asian, and Caucasian patients. Ocul Immunol Inflamm. 2021;29(1):160–168. doi:10.1080/09273948.2019.1662059.
   PubMed Web of Science ®Google Scholar